Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons

Authors

Jong‐Mu Sun (ORCID: https://orcid.org/0000-0003-1800-5881)
Lin Zhan (ORCID: https://orcid.org/0000-0002-0230-7159)
Jaffer A. Ajani (ORCID: https://orcid.org/0000-0001-9946-0629)
Maximiliano Augusto Novis de Figueiredo
Georgios F. Nikolaidis (ORCID: https://orcid.org/0000-0001-9008-6896)
Anastasios Tasoulas (ORCID: https://orcid.org/0009-0004-3709-639X)
K. Wang (ORCID: https://orcid.org/0009-0005-0537-978X)
J. Coaquira Castro (ORCID: https://orcid.org/0009-0001-7063-2420)
Konstantinos Soulanis

Institutions

The University of Texas MD Anderson Cancer Center (US)
Universidade Estadual de Campinas (UNICAMP) (BR)
Samsung Medical Center (KR)
IQVIA (United Kingdom) (GB)
Synthesis and Research (Greece) (GR)
Universidad San Carlos (PY)

Publication Details

Journal: Advances in Therapy
Published: 2025-12-03
DOI: https://doi.org/10.1007/s12325-025-03410-5
Primary Topic: Esophageal Cancer Research and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons

Jong‐Mu Sun, Lin Zhan, Jaffer A. Ajani, Maximiliano Augusto Novis de Figueiredo et al.

Dec 3, 2025

Advances in Therapy

Esophageal Cancer Research and Treatment

article

Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons

Jong‐Mu Sun, Lin Zhan, Jaffer A. Ajani, Maximiliano Augusto Novis de Figueiredo, Georgios F. Nikolaidis, Anastasios Tasoulas, K. Wang, J. Coaquira Castro, Konstantinos Soulanis

December 3, 2025article en

Abstract

No abstract available for this paper.

Advances in TherapyVol. 43(2)

The University of Texas MD Anderson Cancer Center (US), Universidade Estadual de Campinas (UNICAMP) (BR), Samsung Medical Center (KR), IQVIA (United Kingdom) (GB), Synthesis and Research (Greece) (GR), Universidad San Carlos (PY)

Openalex Percentile: Top 43%

Esophageal Cancer Research and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons — Jong‐Mu Sun, Lin Zhan, et al. · Advances in Therapy (2025) | TGRS Research Map | TGRS